CD40 and breast carcinoma: To address this need, here we developed an in vitro heterotypic human macrophage-ER+ PR+ HER2+ breast cancer cell 3D model, referred to as macrophage-tumor spheroid (MTS), and used it to investigate the effect of dual CSF1/CSF1R inhibition and CD40 activation.